OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 114, Issue 4, Pages 732-737 (April 2007)


View previous. 22 of 48 View next.

Age-Related Macular Degeneration Is Associated with Incident Myocardial Infarction among Elderly Americans

Yinkang Duan, MD, MS1, Jingping Mo, MD, PhD21, Ronald Klein, MD, MPH3, Ingrid U. Scott, MD, MPH1, Hung-Mo Lin, PhD1, Joanne Caulfield, MS1, Manju Patel, MD21, Duanping Liao, MD, PhD1Corresponding Author Informationemail address

Received 17 April 2006; accepted 18 July 2006. published online 20 December 2006.

Objective

To investigate whether age-related macular degeneration (AMD) is associated with the development of myocardial infarction (MI) among elderly Americans.

Design

Population-based cross-sectional and cohort study.

Participants

Five percent random sample of 2000 to 2003 Medicare enrollees.

Methods

The cross-sectional study included the first 2-year (2000 and 2001) enrollees who were aged ≥65 years (n = 1519086). The cohort study included only baseline MI-free enrollees (n = 1445677).

Main Outcome Measures

Chronic conditions (AMD and type, history of MI, hypertension, and diabetes) were defined based on any occurrence of relevant International Classification of Diseases 9 codes in relevant diagnosis fields of the baseline Medicare claim files. A total of 56611 incident MI cases were identified from the follow-up data (2002 and 2003).

Results

Baseline mean age was 76 years, with 60% women and 88% whites. The prevalence of neovascular AMD was 2.2% (2.3% in women vs. 1.7% in men and 2.3% in whites vs. 1.2% in blacks; P<0.01 for both gender and race differences). The prevalence of nonneovascular AMD was 8.8% (9.9% in women vs. 7.3% in men and 9.5% in whites vs. 4.3% in blacks; P<0.01 for both gender and race differences). Baseline age-, gender-, and race-adjusted prevalences of hypertension, diabetes, and history of MI were 75%, 33%, and 5.00%, respectively, in the neovascular AMD group. In contrast, they were 73%, 27%, and 4.68% in the nonneovascular AMD group, and 65%, 25%, and 4.54% in the non-AMD group (P<0.01 for comparing the prevalence in neovascular and nonneovascular AMD vs. non-AMD groups). Prospectively, baseline age-, gender-, race-, hypertension-, and diabetes-adjusted 2-year incident odds ratios and 95% confidence intervals of MI associated with AMD are 1.19 (1.16–1.22) for all persons with AMD, 1.26 (1.20–1.33) for neovascular AMD, and 1.18 (1.14–1.21) for nonneovascular AMD.

Conclusions

AMD is associated with older age, female gender, being white, and having a history of MI, hypertension, and diabetes. Furthermore, presence of AMD, especially neovascular AMD, is prospectively associated with a higher risk of incident MI. These findings, if confirmed by other studies that control for smoking and other lifestyle covariables, suggest the possibility of shared common antecedents between MI and AMD.

1 Pennsylvania State University College of Medicine, Hershey, Pennsylvania.

2 Pfizer Inc., New York, New York.

3 University of Wisconsin—Madison, Madison, Wisconsin.

Corresponding Author InformationCorrespondence to Dr Duanping Liao, Department of Health Evaluation Sciences, Penn State College of Medicine, 600 Centerview Drive, A210, Hershey, PA, 17033.

 Manuscript no. 2006-435.

 Partially funded by a research grant from Pfizer Inc.

1 Drs Mo and Patel are employees of Pfizer Inc.

PII: S0161-6420(06)01177-8

doi:10.1016/j.ophtha.2006.07.045


View previous. 22 of 48 View next.